rs180177042
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs387906660
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs387906661
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs397507466
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397516895
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs113488022
|
|
|
0.750 |
GeneticVariation |
BEFREE |
V599E BRAF mutation was uncommon in Japanese lung cancer.
|
16376942 |
2006 |
rs121913377
|
|
|
0.050 |
GeneticVariation |
BEFREE |
V599E BRAF mutation was uncommon in Japanese lung cancer.
|
16376942 |
2006 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.
|
22743296 |
2012 |
rs113488022
|
|
|
0.750 |
GeneticVariation |
BEFREE |
Accordingly, the combination of MEK inhibitor with EGFR inhibitor was effective at shrinking tumors in mouse model of BRAF non-V600E mutant lung cancer.
|
29348459 |
2018 |
rs121913377
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Accordingly, the combination of MEK inhibitor with EGFR inhibitor was effective at shrinking tumors in mouse model of BRAF non-V600E mutant lung cancer.
|
29348459 |
2018 |
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
rs1057519719
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
rs1057519720
|
|
AA |
0.700 |
CausalMutation |
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
rs121913355
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
rs121913369
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines.
|
19238210 |
2009 |
rs113488022
|
|
|
0.750 |
GeneticVariation |
BEFREE |
BRAF V600E is an emerging drug target in lung cancer, but the clinical significance of non-V600 BRAF mutations in lung cancer and other malignancies is less clear.
|
24035431 |
2013 |
rs121913377
|
|
|
0.050 |
GeneticVariation |
BEFREE |
BRAF V600E is an emerging drug target in lung cancer, but the clinical significance of non-V600 BRAF mutations in lung cancer and other malignancies is less clear.
|
24035431 |
2013 |
rs121913351
|
|
A |
0.800 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs113488022
|
|
T |
0.750 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs1057519719
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs1057519720
|
|
AA |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913355
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913369
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
BRAF and RAS mutations in human lung cancer and melanoma.
|
12460918 |
2002 |
rs121913369
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.
|
22798288 |
2012 |